[Superficial pT1G3 bladder tumor: 24 case reports].
The authors report 24 patients presenting a transitional tumor of bladder pT1G3 collected between January 1996 and December 2000. They represent 19% of the superficial tumors of bladder. Two patients had of straightaway a cystectomy after resection for an unverifiable tumor by endoscopy and another after a second resection discovering a real pT2. Only 5 patients received a BCG therapy is 24% of the cases. A recurrence without progression has been noted in 38% of the cases and a progression in 19% of the patients. These last patients had a cystectomy and with a follow-up to 28 months, no recurrence has been noted.
Benchekroun
A
A
Service d'urologie A, CHU Ibn-Sina, Rabat, Maroc.
el Alj
H A
HA
el Sayegh
H
H
Lachkar
A
A
Nouini
Y
Y
Benslimane
L
L
Belahnech
Z
Z
Faik
M
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000627:therapeutic use; D015653:Cystectomy; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery*
C087507:BCG Connaught; D001500:BCG Vaccine
Les tumeurs superficielles de vessie pT1G3: à propos de 24 cas.